Exercise improvements in ivacaftor treated G551D cystic fibrosis patients are not solely related to FEV1 and sweat changes

Dominic Keating (Melbourne, Australia), Deidre Edgeworth, Dominic Keating, Elyssa Williams, Denise Clark, Brenda Button, Audrey Tierney, Tom Kotsimbos, John Wilson

Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session: Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Session type: Poster Discussion
Number: 2047
Disease area: Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Dominic Keating (Melbourne, Australia), Deidre Edgeworth, Dominic Keating, Elyssa Williams, Denise Clark, Brenda Button, Audrey Tierney, Tom Kotsimbos, John Wilson. Exercise improvements in ivacaftor treated G551D cystic fibrosis patients are not solely related to FEV1 and sweat changes. Eur Respir J 2015; 46: Suppl. 59, 2047

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung function, weight, and sweat chloride responses in patients with cystic fibrosis and the G551D-CFTR mutation treated with ivacaftor: A secondary analysis
Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment
Year: 2013


Regular exercise improves airway inflammation in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Exercise in cystic fibrosis
Source: Eur Respir Monogr 2014; 64: 203-218
Year: 2014


Exercise training in patients with cystic fibrosis
Source: ERS Course 2020 - Pulmonary rehabilitation
Year: 2020


Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

Single-breath washout and association with structural lung changes in children with cystic fibrosis
Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease
Year: 2016


Exercise testing and multiple breath washout as markers of lung disease among patients with cystic fibrosis
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Exercise testing in adults with cystic fibrosis
Source: Eur Respir Monogr 2018; 80: 216-221
Year: 2018


Exercise capacity in patients with cystic fibrosis vs non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Mechanisms that underlie exercise limitation in various respiratory diseases
Year: 2018

Dynamic hyperinflation causes exercise limitation in patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014

Lung function and early abnormality of glucose tolerance (GT) in cystic fibrosis (CF) patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


Lung clearance index and exercise capacity among children with CF and non-CF bronchiectasis over a two year period
Source: International Congress 2015 – Clinical physiology: mechanisms of symptoms and exercise limitations in health and disease
Year: 2015


Assessment of aerobic fitness in cystic fibrosis and asthmatic children
Source: International Congress 2014 – Respiratory function at rest and during exercise
Year: 2014


Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Exercise may improve airway clearance and alleviate hyperinflation in children with Cystic Fibrosis
Source: International Congress 2018 – Improvements in the assessment of paediatric physiology
Year: 2018


What’s the role of stroke volume and cardiac output during exercise in cystic fibrosis?
Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous
Year: 2015

Lung clearance index predicts pulmonary exacerbations in cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014